Cargando…
An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417730/ https://www.ncbi.nlm.nih.gov/pubmed/34489706 http://dx.doi.org/10.3389/fphar.2021.717757 |
_version_ | 1783748440622104576 |
---|---|
author | Tallei, Trina Ekawati Fatimawali, Yelnetty, Afriza Idroes, Rinaldi Kusumawaty, Diah Emran, Talha Bin Yesiloglu, Talha Zahid Sippl, Wolfgang Mahmud, Shafi Alqahtani, Taha Alqahtani, Ali M. Asiri, Saeed Rahmatullah, Mohammed Jahan, Rownak Khan, Md. Arif Celik, Ismail |
author_facet | Tallei, Trina Ekawati Fatimawali, Yelnetty, Afriza Idroes, Rinaldi Kusumawaty, Diah Emran, Talha Bin Yesiloglu, Talha Zahid Sippl, Wolfgang Mahmud, Shafi Alqahtani, Taha Alqahtani, Ali M. Asiri, Saeed Rahmatullah, Mohammed Jahan, Rownak Khan, Md. Arif Celik, Ismail |
author_sort | Tallei, Trina Ekawati |
collection | PubMed |
description | The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as well as several other important parts of this virus, have recently undergone mutations, resulting in new virus variants. While no treatment is currently available, a naturally derived molecule with known antiviral properties could be used as a potential treatment. Bromelain is an enzyme found in the fruit and stem of pineapples. This substance has been shown to have a broad antiviral activity. In this article, we analyse the ability of bromelain to counteract various variants of the SARS-CoV-2 by targeting bromelain binding on the side of this viral interaction with human angiotensin-converting enzyme 2 (hACE2) using molecular docking and molecular dynamics simulation approaches. We have succeeded in making three-dimensional configurations of various RBD variants using protein modelling. Bromelain exhibited good binding affinity toward various variants of RBDs and binds right at the binding site between RBDs and hACE2. This result is also presented in the modelling between Bromelain, RBD, and hACE2. The molecular dynamics (MD) simulations study revealed significant stability of the bromelain and RBD proteins separately up to 100 ns with an RMSD value of 2 Å. Furthermore, despite increases in RMSD and changes in Rog values of complexes, which are likely due to some destabilized interactions between bromelain and RBD proteins, two proteins in each complex remained bonded, and the site where the two proteins bind remained unchanged. This finding indicated that bromelain could have an inhibitory effect on different SARS-CoV-2 variants, paving the way for a new SARS-CoV-2 inhibitor drug. However, more in vitro and in vivo research on this potential mechanism of action is required. |
format | Online Article Text |
id | pubmed-8417730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84177302021-09-05 An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants Tallei, Trina Ekawati Fatimawali, Yelnetty, Afriza Idroes, Rinaldi Kusumawaty, Diah Emran, Talha Bin Yesiloglu, Talha Zahid Sippl, Wolfgang Mahmud, Shafi Alqahtani, Taha Alqahtani, Ali M. Asiri, Saeed Rahmatullah, Mohammed Jahan, Rownak Khan, Md. Arif Celik, Ismail Front Pharmacol Pharmacology The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as well as several other important parts of this virus, have recently undergone mutations, resulting in new virus variants. While no treatment is currently available, a naturally derived molecule with known antiviral properties could be used as a potential treatment. Bromelain is an enzyme found in the fruit and stem of pineapples. This substance has been shown to have a broad antiviral activity. In this article, we analyse the ability of bromelain to counteract various variants of the SARS-CoV-2 by targeting bromelain binding on the side of this viral interaction with human angiotensin-converting enzyme 2 (hACE2) using molecular docking and molecular dynamics simulation approaches. We have succeeded in making three-dimensional configurations of various RBD variants using protein modelling. Bromelain exhibited good binding affinity toward various variants of RBDs and binds right at the binding site between RBDs and hACE2. This result is also presented in the modelling between Bromelain, RBD, and hACE2. The molecular dynamics (MD) simulations study revealed significant stability of the bromelain and RBD proteins separately up to 100 ns with an RMSD value of 2 Å. Furthermore, despite increases in RMSD and changes in Rog values of complexes, which are likely due to some destabilized interactions between bromelain and RBD proteins, two proteins in each complex remained bonded, and the site where the two proteins bind remained unchanged. This finding indicated that bromelain could have an inhibitory effect on different SARS-CoV-2 variants, paving the way for a new SARS-CoV-2 inhibitor drug. However, more in vitro and in vivo research on this potential mechanism of action is required. Frontiers Media S.A. 2021-08-20 /pmc/articles/PMC8417730/ /pubmed/34489706 http://dx.doi.org/10.3389/fphar.2021.717757 Text en Copyright © 2021 Tallei, Fatimawali, Yelnetty, Idroes, Kusumawaty, Emran, Yesiloglu, Sippl, Mahmud, Alqahtani, Alqahtani, Asiri, Rahmatullah, Jahan, Khan and Celik. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Tallei, Trina Ekawati Fatimawali, Yelnetty, Afriza Idroes, Rinaldi Kusumawaty, Diah Emran, Talha Bin Yesiloglu, Talha Zahid Sippl, Wolfgang Mahmud, Shafi Alqahtani, Taha Alqahtani, Ali M. Asiri, Saeed Rahmatullah, Mohammed Jahan, Rownak Khan, Md. Arif Celik, Ismail An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants |
title | An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants |
title_full | An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants |
title_fullStr | An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants |
title_full_unstemmed | An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants |
title_short | An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants |
title_sort | analysis based on molecular docking and molecular dynamics simulation study of bromelain as anti-sars-cov-2 variants |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417730/ https://www.ncbi.nlm.nih.gov/pubmed/34489706 http://dx.doi.org/10.3389/fphar.2021.717757 |
work_keys_str_mv | AT talleitrinaekawati ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT fatimawali ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT yelnettyafriza ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT idroesrinaldi ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT kusumawatydiah ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT emrantalhabin ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT yesiloglutalhazahid ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT sipplwolfgang ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT mahmudshafi ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT alqahtanitaha ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT alqahtanialim ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT asirisaeed ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT rahmatullahmohammed ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT jahanrownak ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT khanmdarif ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT celikismail ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT talleitrinaekawati analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT fatimawali analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT yelnettyafriza analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT idroesrinaldi analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT kusumawatydiah analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT emrantalhabin analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT yesiloglutalhazahid analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT sipplwolfgang analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT mahmudshafi analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT alqahtanitaha analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT alqahtanialim analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT asirisaeed analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT rahmatullahmohammed analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT jahanrownak analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT khanmdarif analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants AT celikismail analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants |